Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Lasica, R. (14631892300)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Prognostic Significance of Atrial Fibrillation in Lower Limb Amputee Patients
    (2016)
    Ralevic, S. (25947799400)
    ;
    Perunicic, J. (9738988200)
    ;
    Lasica, R. (14631892300)
    ;
    Marinkovic, J. (7004611210)
    ;
    Blagojevic, T. (57192159614)
    ;
    Simanic, I. (55427466600)
    ;
    Asanin, M. (8603366900)
    ;
    Stankovic, G. (59150945500)
    Objective In patients with risk factors or established atherothrombosis, atrial fibrillation (AF) is associated with a poor prognosis compared with patients without AF. The aim of this study was to evaluate the prevalence of AF in patients with lower limb amputation (LLA) and its association with cardiovascular death and adverse cardiovascular events in long-term follow-up. Methods Observational prospective study of consecutive patients after index major (transfemoral and transtibial) LLA. The primary endpoint was cardiovascular death and secondary endpoint was a composite of adverse cardiovascular events at follow-up (acute myocardial infarction, contralateral lower limb amputation, and ischaemic stroke). Results Of 282 patients with LLA, 46 (16.3%) patients had AF. AF patients were significantly older compared with patients without AF (median 74.0, IQR 13.0 vs. median 67.0, IQR 14.8 years, p <.001). Diabetes and smoking on the other hand were significantly less prevalent in patients with AF compared with those without AF (41.3% vs. 72.0%, p <.001 and 56.5% vs. 76.3%, p = .01, respectively). 54.3% of patients with AF were on oral anticoagulation therapy. At a median follow-up of 24.0 months (IQR 19.0–32.0), 28.3% patients with AF died of cardiovascular causes versus 17.8% without AF (HRR 1.8, 95% CI 1.0–3.4, p = .06). Adverse cardiovascular events occurred in 32.6% of patients with AF during follow-up versus 22.0% without AF (HRR 1.9, 95% CI 1.0–3.3, p = .03). In multivariate Cox regression analysis, AF (HRR 2.3, 95% CI 1.3–4.2, p = .01) and diabetes (HRR 2.1, 95% CI 1.1–3.9, p = .02) were identified as independent predictors of adverse cardiovascular events during the follow-up. Conclusion AF is common in patients with LLA and associated with higher risk of adverse cardiovascular events during long-term follow-up. © 2016 European Society for Vascular Surgery
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome
    (2011)
    Gostiljac, D. (13409402200)
    ;
    Dorević, P. (37664790300)
    ;
    Djurić, Dragan (36016317400)
    ;
    Peruničić, J. (9738988200)
    ;
    Lasica, R. (14631892300)
    ;
    Čolak, E. (56216778500)
    ;
    Canovic, F. (24398651900)
    ;
    Srećković, V. (36195903600)
    ;
    Ilić, M. (37665062700)
    ;
    Obrenović, R. (56199010700)
    Acute coronary syndrome (ACS) is the main cause of mortality in diabetics. Acute myocardial infarction (AMI) in diabetics is much more often than in non-diabetics. MMP-9 activity could ease the formation of atherosclerosis, destabilization and plaque rupture as well as thrombocyte aggregation. The aim of this study is to examine: MMP-9 defining in serum in diabetics; the impact of diabetes mellitus on atherosclerosis and MMP-9 level; relation between serum values of MMP-9 and markers of glycoregulation and lipid status, respectively. Results: The greatest concentration of both total and active MMP-9 serum has been noted in diabetics group with ACS. Both total and active MMP-9 values, in group with diabetes and ACS showed significantly important difference regarding the values in control group. Total and active MMP-9 showed statistically important correlation between the values of glycated hemoglobine A1c (HbA1c) and inverse correlations with values of subfraction HDL3.Active MMP-9 showed statistically important inverse correlation with value of HDL cholesterol. In conclusion: According to the results, it has been thought that active MMP-9 shows a certain degree of atherosclerotic changes on blood vessels better than total MMP-9. MMP-9, active one, could present an early marker of atherosclerosis, especially on coronary blood vessels, in diabetics with type 2. © 2011 Akadémiai Kiadó, Budapest.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback